Granite Investment Partners’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-443,025
Closed -$5.84M 301
2015
Q3
$5.84M Buy
443,025
+11,184
+3% +$169K 0.56% 75
2015
Q2
$7.08M Buy
431,841
+15,239
+4% +$253K 0.65% 51
2015
Q1
$7.41M Buy
416,602
+223,751
+116% +$4.16M 0.64% 57
2014
Q4
$3.67M Buy
192,851
+74,503
+63% +$1.26M 0.41% 67
2014
Q3
$1.62M Buy
118,348
+56,843
+92% +$811K 0.22% 133
2014
Q2
$1M Buy
+61,505
New +$890K 0.14% 150

Other funds holding ANGO

Granite Investment Partners's ANGO Position: Q4 2015 in Review

Granite Investment Partners sold out of AngioDynamics (ANGO) in Q4 2015, closing a stake of 443,025 shares — an estimated $5.84M sold.

Granite Investment Partners first reported a position in ANGO in Q2 2014 and held it in 6 quarters. The position peaked at $7.41M in Q1 2015. 121 funds tracked by Wall St. Rank hold ANGO as of Q4 2015.

  • Granite Investment Partners reported no remaining AngioDynamics position as of Q4 2015 after selling out during the quarter.
  • Granite Investment Partners sold 443,025 AngioDynamics shares in Q4 2015, an estimated $5.84M.
  • Granite Investment Partners first reported a position in AngioDynamics in Q2 2014 and held it in 6 quarters.
  • Granite Investment Partners's AngioDynamics position peaked at $7.41M in Q1 2015.
  • 121 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2015.

Based on Granite Investment Partners's 13F filing for Q4 2015, filed 11 Feb 2016.